Pete Strong
London, ENG WC2A1AP, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected mice: Pulmonary PK-PD analysis of anti-fungal PC945.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 13, 2020
PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections.
Journal: Journal of fungi (Basel, Switzerland)
Published: October 06, 2020
Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent.
Journal: Pharmacology research & perspectives
Published: September 28, 2020
Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study.
Journal: The Journal of infectious diseases
Published: August 19, 2020
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
Journal: Scientific reports
Published: March 20, 2019
In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
Journal: The Journal of antimicrobial chemotherapy
Published: March 05, 2019
Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
Journal: The Journal of antimicrobial chemotherapy
Published: February 25, 2019
Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
Journal: British journal of pharmacology
Published: September 26, 2017
In Vitro and In Vivo Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus Infection.
Journal: Antimicrobial agents and chemotherapy
Published: September 15, 2017
Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
Journal: Antimicrobial agents and chemotherapy
Published: April 07, 2017
Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice.
Journal: Mycoses
Published: February 13, 2017
In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice.
Journal: Antimicrobial agents and chemotherapy
Published: January 20, 2017
Last Updated: 09/26/2026